Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer (Q33486920)
scientific article
Language:
Current Data About Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer
(P31) (Q13442814)
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P304) 253-255
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P478) 46
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P577) Tuesday, July 1, 1980
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P921) (Q42824440)

(P1433) (Q326041)
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P1476) "Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer" (language: en)
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P2093) Mouridsen HT
(P1545) 1
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

Kristensen D
(P1545) 2
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

Nielsen JH
(P1545) 3
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

Dombernowsky P
(P1545) 4
(P248)
(P698) 7388770
(P813) Thursday, July 27, 2017

(P2860) (Q33489133)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1097-0142%2819800715%2946%3A2%3C253%3A%3AAID-CNCR2820460205%3E3.0.CO%3B2-1
(P813) Sunday, January 21, 2018

other details